Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Levomepromazine maleate 33.8mg equivalent to levomepromazine 25mg; ;
Clinect NZ Pty Limited
25 mg
Tablet
Active: Levomepromazine maleate 33.8mg equivalent to levomepromazine 25mg Excipient: Colloidal hydrated silica Dextrin Hypromellose Iron oxide yellow Lactose monohydrate Macrogol 6000 Magnesium stearate Titanium dioxide Wheat starch
Prescription
Psychiatry As an alternative to Largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity.
Package - Contents - Shelf Life: Blister pack, - 100 tablets - 36 months from date of manufacture stored at or below 25°C protect from light
2019-12-02
NOZINAN ® (Swiss stock) Page 1 _ _ NOZINAN ® TABLETS (SWISS STOCK) _LEVOMEPROMAZINE MALEATE _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Nozinan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT NOZINAN IS USED FOR Nozinan is a type of neuroleptic used in both psychiatry and severe pain. It is not known exactly how Nozinan has these effects. The effect of Nozinan is to relieve severe pain without making you feel sick or vomit. It relieves the anxiety and distress associated with severe pain. Nozinan can also be used to treat schizophrenia. Your doctor, however, may prescribe Nozinan for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FOR YOU. This medicine is only available with a doctor’s prescription. There is no evidence that this medicine is addictive. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE NOZINAN IF YOU HAVE: • liver disease • heart disease • urinary or prostate problems • increased pressure in the eye (glaucoma) • a history of a lack of white blood cells (agranulocytosis) DO NOT TAKE NOZINAN IF YOU ARE ALLERGIC TO IT OR OTHER MEDICINES SIMILAR TO NOZINAN CALLED PHENOTHIAZINES OR ARE ALLERGIC TO ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Some symptoms of an allergic reaction include skin rash, itching, shortness of breath or swelling of the face, lips or tongue, which may cause difficulty in swallowing or breathing. If you experience an allergic reaction, seek medical help right away. DO NOT TAKE IT AFTER THE EXPIRY DATE (EXP) PRINTED ON THE PACK. If you take it after the ex Read the complete document
1 NEW ZEALAND DATA SHEET 1. NOZINAN TABLETS (SWISS STOCK) Nozinan (Swiss stock) 25 mg and 100 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Levomepromazine 25mg equivalent to 33.75 mg levomepromazine maleate Levomepromazine 100mg equivalent to 135 mg levomepromazine maleate. Excipient with known effect: lactose monohydrate. For the full list of excipients, see section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Beige, biconvex film-coated tablets indented ' NN 25' and 'NN 100 ' respectively on one face with a break- line on the reverse. The diameter of the 25 mg tablets is 9 mm and the 100 mg tablets 12 mm. The tablet can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _PSYCHIATRY _ As an alternative to Largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity. _GENERAL MEDICINE _ Alone or together with appropriately modified doses of analgesics and narcotics, in the relief of severe pain and accompanying anxiety and distress. 4.2 DOSE AND METHOD OF ADMINISTRATION Dosage varies with the condition and the individual response of the patient. THE BELOW RECOMMENDED DOSES REFER TO THE AMOUNT OF LEVOMEPROMAZINE MALEATE CONTAINED IN THE NOZINAN TABLETS. _TERMINAL ILLNESS _ Nozinan tablets 25 mg may be substituted for the injection if oral therapy is more convenient. The dosage is 12.5 - 50 mg every 4 - 8 hours. ELDERLY No specific dosage recommendations. _PSYCHIATRY _ ADULTS Ambulant patients: 2 Initially the total daily dose should not exceed 25 - 50 mg, usually divided into three doses. A larger portion of the dosage may be taken at bedtime to minimise diurnal sedation. The dosage is then gradually increased to the most effective level coupled with minimum side-effects. Bed patients: Initially the total dosage may be 100 mg to 200 mg, usually divided into three doses, gradually increased to 1 g daily if necessary. Attempts should be made when the patient is stable to reduce the dosage to an adequate maintenance level. CHILDREN Children are v Read the complete document